The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments

Ther Drug Monit. 2006 Dec;28(6):720-5. doi: 10.1097/FTD.0b013e31802c5cf5.
No abstract available

Publication types

  • Review

MeSH terms

  • Cyclosporine / pharmacokinetics
  • Drug Monitoring*
  • Everolimus
  • Humans
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use*
  • Mycophenolic Acid / pharmacokinetics
  • Organ Transplantation
  • Protein Kinases / metabolism
  • Sirolimus / analogs & derivatives
  • Sirolimus / pharmacokinetics
  • TOR Serine-Threonine Kinases
  • Tacrolimus / pharmacokinetics

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Everolimus
  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Mycophenolic Acid
  • Sirolimus
  • Tacrolimus